TY  - GEN
AU  - Yamamoto,Kei
AU  - Makino,Tomoki
AU  - Sato,Eiichi
AU  - Noma,Toshiki
AU  - Urakawa,Shinya
AU  - Takeoka,Tomohira
AU  - Yamashita,Kotaro
AU  - Saito,Takuro
AU  - Tanaka,Koji
AU  - Takahashi,Tsuyoshi
AU  - Kurokawa,Yukinori
AU  - Yamasaki,Makoto
AU  - Nakajima,Kiyokazu
AU  - Mori,Masaki
AU  - Doki,Yuichiro
AU  - Wada,Hisashi
TI  - Tumor-infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer
SN  - 1349-7006
PY  - 2020///0422
KW  - Aged
KW  - Antigens, CD
KW  - blood
KW  - Antigens, Differentiation, Myelomonocytic
KW  - Biomarkers, Tumor
KW  - Biopsy
KW  - Cell Lineage
KW  - drug effects
KW  - Cisplatin
KW  - administration & dosage
KW  - Disease-Free Survival
KW  - Docetaxel
KW  - Esophageal Neoplasms
KW  - Female
KW  - Fluorouracil
KW  - Forkhead Transcription Factors
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Leukocyte Count
KW  - Lymphocytes, Tumor-Infiltrating
KW  - Macrophages
KW  - Male
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Prognosis
KW  - Programmed Cell Death 1 Receptor
KW  - Receptors, Cell Surface
KW  - Tumor Microenvironment
KW  - CD163 Antigen
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1111/cas.14328
ER  -